Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5269517
Max Phase: Preclinical
Molecular Formula: C53H94O15
Molecular Weight: 971.32
Associated Items:
ID: ALA5269517
Max Phase: Preclinical
Molecular Formula: C53H94O15
Molecular Weight: 971.32
Associated Items:
Canonical SMILES: CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](CO[C@@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCCCC
Standard InChI: InChI=1S/C53H94O15/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-45(56)66-41(38-63-44(55)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2)39-64-52-51(62)49(60)47(58)43(68-52)40-65-53-50(61)48(59)46(57)42(37-54)67-53/h6,8,12,14,18,21,41-43,46-54,57-62H,3-5,7,9-11,13,15-17,19-20,22-40H2,1-2H3/b8-6-,14-12-,21-18-/t41-,42-,43-,46+,47+,48+,49+,50-,51-,52-,53+/m1/s1
Standard InChI Key: OIRUGIMQBBXNMQ-WKJPABOFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 971.32 | Molecular Weight (Monoisotopic): 970.6593 | AlogP: 7.71 | #Rotatable Bonds: 41 |
Polar Surface Area: 231.13 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 7 |
#RO5 Violations: 4 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 11.91 | CX Basic pKa: | CX LogP: 10.04 | CX LogD: 10.04 |
Aromatic Rings: 0 | Heavy Atoms: 68 | QED Weighted: 0.02 | Np Likeness Score: 1.10 |
1. Govindarajan M.. (2018) Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics., 143 [PMID:29126728] [10.1016/j.ejmech.2017.10.015] |
Source(1):